Inactive Instrument

Press Releases CS MEDICA A/S

Stocks

CSMED

DK0061668225

Press Releases

25-01-10	CS MEDICA Achieves Fourth European Patent with Psoriasis Gel	AQ
25-01-09	CS MEDICA: CEO Letter: A Moment of Transition for CS MEDICA	PU
25-01-09	CEO Letter: A Moment of Transition for CS MEDICA	AQ
25-01-01	Update from Chairperson: Delisting of CS MEDICA A/S from Spotlight Stock Market	AQ
24-12-23	CS MEDICA Explores Listing and Strategic Options to Protect Shareholder & Company Value	AQ
24-12-19	CS MEDICA: CS MEDICA Responds to Spotlight Stock Market’s Delisting Notification	PU
24-12-19	CS MEDICA Responds to Spotlight Stock Market's Delisting Notification	AQ
24-12-19	CS MEDICA: CS MEDICA's Subsidiary CANNORDIC Marks Milestone with First Invoice to Iraq	PU
24-12-19	CS MEDICA's Subsidiary CANNORDIC Marks Milestone with First Invoice to Iraq	AQ
24-11-30	CS MEDICA: CS MEDICA: Q4 Interim report, July – September 2024	PU
24-11-30	CS MEDICA: Q4 Interim report, July - September 2024	AQ
24-11-22	CS MEDICA: Update on the Share Distribution of CANNORDIC Shares	PU
24-11-22	Update on the Share Distribution of CANNORDIC Shares	AQ
24-11-22	CS MEDICA: CS MEDICA Welcomes the Danish Government's Proposal to Make the Pilot Program for Prescription-Based Medicinal Cannabis Permanent	PU
24-11-22	CS MEDICA Welcomes the Danish Government's Proposal to Make the Pilot Program for Prescription-Based Medicinal Cannabis Permanent	AQ
24-11-13	CS MEDICA: CS MEDICA Announces Postponement of Financial Reporting Deadlines	PU
24-11-13	CS MEDICA Announces Postponement of Financial Reporting Deadlines	AQ
24-11-12	CS MEDICA: CS MEDICA A/S: Minutes of Extraordinary General Meeting	PU
24-11-12	CS MEDICA A/S: Minutes of Extraordinary General Meeting	AQ
24-11-12	CS MEDICA: CS MEDICA A/S: Update on the Strategic Rationale Behind CANNORDIC IPO and Aim for Capital Increase	PU
24-11-12	CS MEDICA A/S: Update on the Strategic Rationale Behind CANNORDIC IPO and Aim for Capital Increase	AQ
24-11-11	CS MEDICA: CS MEDICA Expands Presence in Eastern Europe through New Partnership	PU
24-11-11	CS MEDICA Expands Presence in Eastern Europe through New Partnership	AQ
24-11-04	CS MEDICA: CORRECTION: CS MEDICA Valued at 17,16 DKK (€2.30 ) per Share Ahead of German IPO, Highlighting Unique Regulatory Position and Growth Potential	PU
24-11-04	CS MEDICA: CS MEDICA Valued at 17,16 DKK (€2.30 ) per Share Ahead of German IPO, Highlighting Unique Regulatory Position and Growth Potential	PU